新辅助治疗后肺癌切除术30天并发症与再入院预测因素:ESTS数据库分析
基于欧洲胸外科医师学会(ESTS)数据库回顾性分析4547例新辅助治疗后行解剖性肺切除的非小细胞肺癌(NSCLC)患者,识别30天并发症与再入院的预测因素,并构建风险评分用于临床围术期管理。
要点
- COPD、既往恶性肿瘤、高血压、年龄和男性与30天并发症独立相关。
- 年龄、术后重大心肺并发症、男性和Clavien-Dindo分级与30天非计划再入院相关。
- 再入院预测模型准确率93.6%(ROC-AUC=0.91),并构建风险评分辅助临床。
核心结论
- 识别了新辅助治疗后肺切除患者30天并发症与再入院的多个术前因素,并构建了准确预测30天非计划再入院的风险评分。
研究设计与样本
- 回顾性分析ESTS数据库2013年1月至2024年12月4547例≥18岁、接受新辅助治疗后非急诊解剖性肺切除(肺叶/双肺叶/全肺)的NSCLC患者。
主要发现
- 30天并发症与COPD(P < .001)、既往恶性肿瘤(P < .001)、动脉高血压(P = .020)、年龄(P < .001)和男性(P = .026)相关;模型准确率92.7%(ROC-AUC = 0.70)。
- 30天非计划再入院与年龄(P < .001)、术后重大心肺并发症(P < .001)、男性(P < .001)和Clavien-Dindo并发症分级(P < .001)相关;模型准确率93.6%(ROC-AUC = 0.91)。
关键数值与推荐
- 30天并发症预测模型纳入COPD、既往恶性肿瘤、动脉高血压、年龄和男性,准确率92.7%(ROC-AUC = 0.70)。
- 30天非计划再入院预测模型纳入年龄、术后重大心肺并发症、男性和Clavien-Dindo分级,准确率93.6%(ROC-AUC = 0.91)。
临床怎么用
- 可将再入院风险评分整合至临床实践,以改善新辅助治疗后肺切除患者的围术期管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Induction treatment followed by curative-intent surgery is a widely used approach for locally advanced non-small cell lung cancer (NSCLC) but is associated with increased postoperative morbidity. This study aimed to identify predictors of 30-day morbidity and unplanned readmission in patients who underwent lung resection for NSCLC after induction therapy, registered in the European Society of Thoracic Surgeons (ESTS) database. METHODS: We retrospectively analysed the ESTS database, including patients who met the following criteria: (1) ≥18 years of age; (2) prior neoadjuvant therapy; (3) non-urgent major anatomical lung resection (lobectomy/bilobectomy/pneumonectomy) for NSCLC (01/2013-12/2024). Logistic regression was used to identify factors associated with 30-day morbidity and unplanned readmission. Two predictive models were developed; model accuracy was evaluated using area under the receiver operating characteristic curve (ROC-AUC) for 30-day morbidity and unplanned readmission. A risk score integrating key predictors was developed for clinical application. RESULTS: A total of 4547 patients were included. Chronic obstructive pulmonary disease (COPD) (P < .001), previous malignancies (P < .001), arterial hypertension (P = .020), age (P < .001), and male sex (P = .026) were associated with 30-day morbidity. The predictive model developed using these factors achieved an accuracy of 92.7% (ROC-AUC = 0.70). Age (P < .001), major postoperative cardiopulmonary complications (P < .001), male sex (P < .001), and Clavien-Dindo complication grading (P < .001) were associated with 30-day unplanned readmission. The predictive model developed using these factors achieved an accuracy of 93.6% (ROC-AUC = 0.91). A predictive score for 30-day unplanned readmission was constructed. CONCLUSIONS: We identified several preoperative factors associated with 30-day morbidity and unplanned readmission after postinduction lung resection. Furthermore, we developed a risk score that accurately predicts 30-day unplanned readmission. This score could be integrated into clinical practice to improve perioperative patient management.
引用
- Prisciandaro E, Bertolaccini L, Passani S, et al. Predictors of 30-day Morbidity and Unplanned Readmission After Induction Therapy Followed by Lung Resection for Non-small Cell Lung Cancer: European Society of Thoracic Surgeons Database Analysis. Eur J Cardiothorac Surg. 2025. PMID: 41308163. doi:10.1093/ejcts/ezaf426
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。